Source:http://linkedlifedata.com/resource/umls/id/C0281743
NCI: A murine monoclonal antibody (MoAb) IgG2a, LL2. MoAb LL2 recognizes CD22, a B-lymphocyte-restricted antigen expressed as a cytoplasmic protein in progenitor B cells, and as a cell surface protein in mature B cells. When labeled with radioisotope, MoAb LL2 targets tumor cells that express CD22 antigen and delivers cytotoxic radiation that may be used to treat B-cell lineage cancers.